Haloperidol for chronically hospitalized psychotics: a double-blind comparison with thiothixene and placebo; a follow-up open evaluation.
Howard
J S
JS
Eastern State Hospital, Williamsburg, Virginia, USA.
D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001291:Attitude of Health Personnel; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use*; D006304:Health Status; D006760:Hospitalization; D006801:Humans; D007902:Length of Stay; D008603:Mental Health; D008875:Middle Aged; D009726:Nurses / Q000523:psychology; D010351:Patient Discharge; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000523:psychology / Q000628:therapy*; D013888:Thiothixene / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D013888:Thiothixene; D006220:Haloperidol